A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Many people in Boston book a Botox appointment focused entirely on the treatment itself, rarely pausing to think about who ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...

Kardigan(TM), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, ...

Georgia Patients Can Now Access Stem Cell and Exosome Therapy Locally. Atlanta residents seeking advanced regenerative ...

Novo Nordisk has launched a subscription-based program for cash-paying patients who have been prescribed Wegovy (semaglutide). Beginning today, patients will be able to access the ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Mass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high-risk patients who did not have known ...